EP3068434 - FORMULATIONS OF AZAINDOLE COMPOUNDS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.06.2020 Database last updated on 02.11.2024 | |
Former | Examination is in progress Status updated on 11.05.2018 | Most recent event Tooltip | 26.06.2020 | Application deemed to be withdrawn | published on 29.07.2020 [2020/31] | Applicant(s) | For all designated states Vertex Pharmaceuticals Inc. 50 Northern Avenue Boston, MA 02210 / US | [2016/38] | Inventor(s) | 01 /
SIMONE, Eric, Arthur 174 Crane Neck Street West Newbury, MA 01985 / US | 02 /
SANGHVI, Tapan 157 Summer St. Apt. 2 Watertown, MA 02472 / US | 03 /
BANDA, Alamelu 819 N. Humboldt Street, Apt. 402 San Marco, CA 94401 / US | 04 /
STAVROPOULOS, Katherine 90 Quincy Shore Dr. Apt 506 Quincy, MA 02171 / US | [2016/38] | Representative(s) | Cohausz & Florack Patent- & Rechtsanwälte Partnerschaftsgesellschaft mbB Bleichstraße 14 40211 Düsseldorf / DE | [2016/38] | Application number, filing date | 14805749.0 | 12.11.2014 | [2016/38] | WO2014US65144 | Priority number, date | US201361903840P | 13.11.2013 Original published format: US 201361903840 P | [2016/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015073491 | Date: | 21.05.2015 | Language: | EN | [2015/20] | Type: | A1 Application with search report | No.: | EP3068434 | Date: | 21.09.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.05.2015 takes the place of the publication of the European patent application. | [2016/38] | Search report(s) | International search report - published on: | EP | 21.05.2015 | Classification | IPC: | A61K45/06, A61K31/497, A61P31/16 | [2016/38] | CPC: |
A61K31/506 (EP,IL,KR,RU,US);
A61K31/16 (EP,IL,US);
A61K31/215 (KR);
A61K31/351 (EP,IL,US);
A61K31/437 (KR);
A61K31/4965 (EP,IL,US);
A61K31/497 (EP,IL,US);
A61K45/06 (EP,IL,KR,US);
A61K47/00 (RU);
A61K47/38 (KR);
A61K9/0019 (RU);
A61K9/08 (RU);
A61K9/16 (KR);
A61K9/2095 (IL,US);
A61P31/16 (EP,IL,RU);
A61K2300/00 (KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/38] | Extension states | BA | 03.05.2016 | ME | 03.05.2016 | Title | German: | FORMULIERUNGEN VON AZAINDOLVERBINDUNGEN | [2016/38] | English: | FORMULATIONS OF AZAINDOLE COMPOUNDS | [2016/38] | French: | FORMULATIONS DE COMPOSÉS AZA-INDOLE | [2016/38] | Entry into regional phase | 03.05.2016 | National basic fee paid | 03.05.2016 | Designation fee(s) paid | 03.05.2016 | Examination fee paid | Examination procedure | 03.05.2016 | Examination requested [2016/38] | 15.02.2017 | Amendment by applicant (claims and/or description) | 14.05.2018 | Despatch of a communication from the examining division (Time limit: M06) | 21.02.2019 | Reply to a communication from the examining division | 17.06.2019 | Despatch of a communication from the examining division (Time limit: M06) | 03.01.2020 | Application deemed to be withdrawn, date of legal effect [2020/31] | 27.01.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/31] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 21.02.2019 | Request for further processing filed | 21.02.2019 | Full payment received (date of receipt of payment) Request granted | 06.03.2019 | Decision despatched | Fees paid | Renewal fee | 10.11.2016 | Renewal fee patent year 03 | 13.11.2017 | Renewal fee patent year 04 | 14.11.2018 | Renewal fee patent year 05 | 14.11.2019 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [YD]US2012171245 (CHARIFSON PAUL S [US], et al); |